View Author
scopus: 35248976100

Oyen, W.J.

(Wim Oyen)


peptide uptake kidney receptor 111 in-octreotide megalin j nucl med trova floxacin abscess albumin 111 in-exendin reabsorption binding radiolabeled peptides radiolabeled effect radiolabelled peptides 111 in-minigastrin study in-octreotide fralb protein imaging radiolabelled floxacin lysine in-exendin trova fragment signi cck 2r cck 2i therapy kidney uptake somatostatin in-minigastrin animal concentration signi ficantly fragili treatment tissue retention mechanism group reduction octreotide injection radionuclide minigastrin jong m radiation result krenning ep ef ficacy 111 in-albumin inhibition bn 16 cells activity endocytosi megalin-deficient mice ficantly megalin-deficient weight radiopeptide netherland model 5 days expression radboud university nijmegen combination tumor spect cancer accumulation medicine • vol peptide #6 inhibitor nephrotoxicity analog




8 Most Recent Publications

Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice (Article)
Vegt, E. Melis, M.L. Eek, A. Visser, M. de Brom, M. Oyen, W.J. Gotthardt, M. Jong, M. de Boerman, O.C.
2011-04-01
Renal toxicity of radiolabeled peptides and antibody fragments: Mechanisms, impact on radionuclide therapy, and strategies for prevention (Article)
Vegt, E. Jong, M. de Wetzels, J.F.M. Masereeuw, R. Melis, M.L. Oyen, W.J. Gotthardt, M. Boerman, O.C.
2010-07-01
Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides (Article)
Vegt, E. Eek, A. Oyen, W.J. Jong, M. de Gotthardt, M. Boerman, O.C.
2010-02-01
Reducing renal uptake of radiolabeled peptides using albumin fragments (Article)
Vegt, E. Eerd, J.E.M. van Eek, A. Oyen, W.J. Wetzels, J.F.M. Jong, M. de Russel, F.G.M. Masereeuw, R. Gotthardt, M. Boerman, O.C.
2008-09-01
Targeting of a CCK2 receptor splice variant with 111In-labelled cholecystokinin-8 (CCK8) and 111In-labelled minigastrin (Article)
Laverman, P. Roosenburg, S. Gotthardt, M. Park, J. Oyen, W.J. Jong, M. de Hellmich, M.R. Rutjes, F.P.J.T. Delft, F.L. van Boerman, O.C.
2008-02-01
A response to 'Nanotechnology and the need for risk governance', O. Renn & M.C. Roco, 2006. J. Nanoparticle Research 8(2): 153-191 (Article)
Bijker, W.E. Beaufort, I.D. de Berg, A. van den Borm, P.J.A. Oyen, W.J. Robillard, G.T. Dijk, H.F.G. van
2007-12-01
Indication for different mechanisms of kidney uptake of radiolabeled peptides (Article)
Gotthardt, M. Eerd-Vismale, J. van Oyen, W.J. Jong, M. de Zhang, H. Rolleman, E.J. Maecke, H.R. Béhé, M. Boerman, O.C.
2007-04-01
In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model. (Article)
Stearne, L.E.T. Gyssens, I.C.J. Goessens, W.H.F. Mouton, J.W. Oyen, W.J. Meer, J.W. van der Verbrugh, H.A.
2001-05-07